Multiple sclerosis active substance of the sheep gift reduces thrusts
Inflammatory events occurring in patients with MS during the episode of stroke lead to lesions in the cerebral or spinal cord area. By default, patients are treated with immunomodulatory therapy to prevent further neurological damage. This therapy does not always lead to success.
Iranian scientists have now investigated whether a herbal therapy using a yarrow extract (Achillea millefolium) in parallel to the standard therapy can increase their effectiveness. The study ran for over a year. For the study, 75 patients with remitting multiple sclerosis were randomized into three groups. Subjects in the first group received 250 mg / day Achillea extract, the second group 500 mg / day Achillea extract, and the third placebo group.
The Achillea extract contained both 0.28 mg / g luteolin and 1.58 mg / g apigenin.
On average, the subjects of the two verum groups suffered significantly less from recurrences. The time to first boost was longer in the verum groups than in the placebo group. The higher dose extract significantly reduced the risk of recurrence and volume of lesions compared to the lower dose and the placebo preparation. In the results of the neuropsychological studies, the Achillea extracts also performed better than placebo. This was also true for cognitive performance as well as managing executive functions (e.g., strategic action planning). In addition, the subjects in the verum groups suffered less from depressive moods. Source. Carstens Foundation